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Abstract
Objective: The impact of childhood differentiated thyroid carcinoma (DTC) on psychosocial development has not yet 
been studied. The aim of this study was to evaluate the achievement of psychosocial developmental milestones in 
long-term survivors of childhood DTC.
Design and methods: Survivors of childhood DTC diagnosed between 1970 and 2013 were included. Reasons for exclusion 
were age <18 or >35 years at follow-up, a follow-up period <5 years or diagnosis with DTC as a second malignant neoplasm. 
Survivors gathered peer controls of similar age and sex (n = 30). A comparison group non-affected with cancer (n = 508) and 
other childhood cancer survivors (CCS) were also used to compare psychosocial development. To assess the achievement of 
psychosocial milestones (social, autonomy and psychosexual development), the course of life questionnaire (CoLQ) was used.
Results: We included 39 survivors of childhood DTC (response rate 83.0%, mean age at diagnosis 15.6 years, and mean 
age at evaluation 26.1 years). CoLQ scores did not significantly differ between survivors of childhood DTC and the 
two non-affected groups. CoLQ scores of childhood DTC survivors were compared to scores of other CCS diagnosed at 
similar ages (n = 76). DTC survivors scored significantly higher on social development than other CCS, but scores were 
similar on autonomy and psychosexual developmental scales.
Conclusions: Survivors of childhood DTC showed similar development on social, autonomy, and psychosexual domains 
compared to non-affected individuals. Social development was slightly more favorable in DTC survivors than in other 
CCS, but was similar on autonomy and psychosexual domains.
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Background
Childhood diagnosis of thyroid cancer is rare. Age-
adjusted incidence rates of pediatric thyroid cancer 
are reported between 0.6 and 1.2 per 100  000 per year, 
but rates are increasing (1, 2, 3). Differentiated thyroid 
carcinoma (DTC) is the most frequently diagnosed 
histological subtype of this disease, accounting for over 
90% of the thyroid cancers in children (1). The incidence 
of childhood DTC peaks during puberty and mainly 
affects girls (4, 5). The effect of DTC on the psychosocial 
development of children diagnosed with this disease has 
not been studied.
Childhood cancer arises in a period where several 
psychosocial developmental milestones are reached 
(6), also referred to as ‘the course of life’ (7). The 
psychosocial development from childhood toward 
adulthood involves increasing independence, growth 
of more symmetrical parent–adolescent relationships, 
maturation of personality and identity, and encountering 
and maintaining (first) psychosexual and social contacts 
(8). The diagnosis and treatment of childhood cancer may 
impair the psychosocial development as some childhood 
cancer survivors (CCS) have been shown to be hindered 
in their development. For example, CCS had fewer friends 
and tended to be older when they experienced their first 
sexual intimacy. However, data are inconclusive (7, 9, 10, 
11, 12). In survivors of various types of childhood cancer 
the biological behavior of the cancer and the impact 
of treatment interfere differently in the course of life: 
survivors of brain tumors seem most severely affected 
(9, 10, 11, 13).
Unfortunately, despite the excellent cure rates, most 
DTC survivors remain patients for the rest of their lives. 
Treatment of DTC consists of a thyroidectomy, and in 
case of lymph node metastases, it is extended with a 
lymph node dissection in the neck. In the Netherlands, 
about a third of the survivors of childhood DTC 
experience surgical complications: the most common 
complications are hypoparathyroidism and recurrent 
laryngeal nerve damage (5). Surgery is followed by one 
or more administrations of radioactive iodine (131-I). 
During the 131-I administrations, patients are withdrawn 
from thyroid hormone for several weeks; this causes 
deep hypothyroidism, involving changes in metabolism 
(14). Initial treatment usually takes from one to several 
years. Subsequently, lifelong thyroid hormone therapy 
is initiated. Especially for high-risk patients, relatively 
high levels of thyroid hormone are prescribed to induce 
subclinical hyperthyroidism, which decreases the risk of 
cancer recurrence (15). However, large fluctuations in 
thyroid hormone levels are known to have a great impact 
on well-being, behavior, and learning ability (16, 17). 
Childhood DTC has an excellent survival, with 5-year 
and 10-year survival rates >95% (4, 5). Furthermore, 
specific aspects of DTC survivorship include lifelong use 
of hormone medication and blood tests as well as the 
possibility of cancer recurrences even after decades of 
disease-free survival (18).
An explorative study was set up, ultimately to evaluate 
whether interventions for these survivors are necessary. 
Our aims were (I) to compare the developmental milestones 
reached by adult survivors of childhood DTC and by 
individuals non-affected with cancer; (II) to compare 
psychosocial development in adult survivors of childhood 
DTC and in survivors of other types of childhood cancer 
and (III) to assess whether the psychosocial development 
of survivors of childhood DTC is associated with medical 
characteristics.
Subjects and methods
This cross-sectional study was performed in the context 
of a Dutch nationwide study examining medical 
characteristics and long-term treatment effects (including 
a paper questionnaire) of childhood DTC from 2012 to 
2014 (5). The Institutional Review Board of the University 
Medical Center Groningen approved the study on behalf 
of all participating institutions (ABR NL40572.042.12, 
file number 2012/183). This study was registered 
in the Netherlands Trial Registry (trial registration 
number 3448).
Participants
DTC survivors
For the nationwide study, all patients diagnosed with DTC 
at age ≤18 years between 1970 and 2013 treated in the 
Netherlands were included (5). Exclusion criteria were, as 
previously reported: follow-up <5  years after diagnosis, 
attained age <18  years, diagnosis of DTC as a second 
malignant neoplasm, lack of understanding of the Dutch 
language, and 131-I administration within three months 
before evaluation (19). For the current study, survivors 
aged >35  years during evaluation were also excluded 
because the questionnaire is validated only up to the age 
of 35 years (7).
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Groups used for comparison
Comparison to individuals unaffected by cancer
DTC survivors were compared to a group of persons 
unaffected by cancer from the survivors’ environment 
(peer controls) and compared to an unaffected group 
reflecting the general population (comparison group).
Peer controls: DTC survivors were asked to find one or 
two peers of the same sex and age (range plus or minus 
5 years from the survivor’s age at evaluation, minimum 
age 18  years). Controls who had a medical history of 
malignancy were excluded. Although we preferred peers 
(e.g. friends, colleagues), we allowed inclusion of family 
members, provided they met the in/exclusion criteria (19). 
For the current substudy, peer controls aged >35  years 
were also excluded.
All DTC survivors and peer controls gave written 
informed consent before participating in the study.
Comparison group: A comparison group, gathered by 
general practitioners in a previous study, was used (7). For 
this comparison, group persons aged 18–30 years, with no 
history of cancer and with the ability to understand Dutch 
questionnaires were included. This group consisted of 508 
persons (consisting of 53% females and 47% males).
Comparison to survivors of other childhood cancers
Survivors of other childhood cancers: 
For this comparison, we used data of other CCS, gathered 
in a study by Stam and coworkers (7). These survivors were 
diagnosed with cancer at age <18 years, were at least 5 years 
in follow-up, aged 17–30 years during evaluation, and were 
able to understand Dutch questionnaires. The different 
cancer diagnoses were grouped as leukemia/lymphoma 
(e.g. acute lymphoblastic leukemia, (non-) Hodgkin 
lymphoma), solid tumors (e.g. rhabdomyosarcoma, 
osteosarcoma) and brain tumors (7). Three hundred and 
fifty-three CCS were eligible for comparison. Survivors of 
thyroid cancer (n = 3) were excluded from analyses since 
we only wanted to compare DTC survivors to other types 
of childhood cancer. Subsequently, 350 CCS of other types 
of cancer (hereafter referred to as CCS) were available 
for comparison.
Measures
Psychosocial development
Psychosocial development was assessed using the 
course of life questionnaire (CoLQ) (7), which measures 
achievement of developmental milestones on five domains: 
(1) social development, (2) autonomy development, (3) 
psychosexual development, (4) antisocial behavior, and 
(5) substance use and gambling. To restrict the length of 
the questionnaire, for the current study only domains 
1–3 were evaluated. Possible scores for each item were 
scored 1 (milestone not (yet) achieved) or 2 (milestone 
achieved). Scores were added-up to form 3 scales: social 
development (12 items, range: 12–24), autonomy 
development (6 items, range: 6–12) and psychosexual 
development (4 items, range: 4–8). Higher scores 
indicate earlier achievement or achievement of more 
developmental milestones. The validity of the course of 
life scales is good. The internal consistency of the scales is 
satisfactory, except the autonomy scale, probably because 
the items refer to diverging aspects of autonomy (7). The 
Cronbach’s alphas in the populations under study were 
moderate to good: (1) social development (range: 12–24): 
DTC survivors 0.70, peer controls 0.76, comparison group 
0.71, CCS 0.75; (2) autonomy development (range: 6–12): 
DTC survivors 0.52, peer controls 0.49, comparison group 
0.49, CCS 0.43; (3) psychosexual development (range: 
4–8): DTC survivors 0.91, peer controls 0.75, comparison 
group 0.71, CCS 0.74.
Sociodemographic and medical data
Sociodemographics (marital status, educational level 
(low, medium and high) and employment status) 
and data regarding disease, treatment, and follow-up 
characteristics were retrieved from medical records and a 
self-administered questionnaire.
Statistical methods
Data are presented as median (interquartile range) unless 
otherwise specified. Characteristics and scores on the CoLQ 
(on scale level and item level) of survivors of childhood 
DTC were compared separately with the characteristics 
or scores of the peer controls, the comparison group 
and the CCS (total, and divided by type of diagnosis). 
Associations between medical characteristics and scores 
on developmental domains were evaluated.
χ2 tests or Fisher’s exact tests (if >20% of the cells 
had an expected count of <5) were used for categorical 
variables. Mann–Whitney U and Kruskal–Wallis tests 
were performed for non-normally distributed continuous 
or ordinal variables. Spearman’s rank correlation 
coefficient was used to correlate two non-normally 
distributed continuous and/or ordinal variables. The 
tests performed are described in the table legends. 
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Missing or unknown values were excluded from statistical 
testing (pairwise deletion). To compensate for multiple 
testing, we considered differences to be statistically 
significant at P < 0.01. All tests were two-sided. IBM SPSS 
Statistics for Windows, version 23 (IBM) was used for 
statistical analyses.
Results
I) Comparison to individuals unaffected with cancer
Sample characteristics
One hundred and five survivors were included in the 
nationwide study (of 169 eligible subjects, response 
rate 62.1%) (5). Of the 47 survivors eligible for the 
current study, 39 (83.0%) participated (Supplementary 
Fig. 1, see section on supplementary data given at the 
end of this article). The survivors gathered 59 peer 
controls, 30 of whom participated: 26 peer controls 
were excluded because of an age >35 years and 3 peer 
controls were excluded because they did not meet 
matching criteria.
Demographic characteristics appear in Table  1. 
Median age of the DTC survivors at evaluation was 
26.2 years (range 18.8–35.7), compared to a median age 
of 25.8 years (range 19.4–34.4, P = 0.628) of peer controls 
and a median age of 23.8  years of the comparison 
group (range 18.0–31.0, P = 0.012). The group of DTC 
survivors had significantly more females than the 
comparison group (87% vs 53%, P < 0.001). DTC survivors 
reported significantly more frequently higher levels of 
education than the comparison group (P = 0.002). Other 
characteristics did not significantly differ between DTC 
survivors and the other two groups.
All DTC survivors and peer controls had the Dutch 
nationality. Ninety-seven percent of the comparison 
group had the Dutch nationality; this was not significantly 
different from the DTC survivors (P = 0.558).
Psychosocial development
Because scores on psychosocial development did not 
differ between males and females in all evaluated groups 
(data not shown), no correction for sex was performed.
Scale scores: Scores of the survivors of childhood DTC 
on all three developmental milestone scales (i.e. social 
development, autonomy development and psychosexual 
development) did not differ significantly from those of 
peer controls or of the comparison group (P = 0.592, 
P = 0.084, P = 0.841, P = 0.233, P = 0.241, and P = 0.556, 
respectively, Table 2).
Table 1 Characteristics of survivors of childhood DTC vs individuals non-affected with cancer.
DTC survivors Peer controls P value Comparison group P value
n 39 30 508
Age at evaluation (years) 26.2 (18.8–35.7) 25.8 (19.4–34.4) 0.628† 23.8 (18.0–31.0) 0.012†
Sex, n (%) 0.690‡ <0.001*§
 Female 34 (87) 28 (93) 269 (53)
 Male 5 (13) 2 (7) 239 (47)
Employment, n (%) 0.576‡ 1.000‡
 Employed and/or student 38 (97) 28 (93) 486 (96)
 Not employed and no student 1 (3) 2 (7) 21 (4)
 Missing 0 (0) 0 (0) 1 (0)
Completed education, n (%) 0.035‡ 0.002*§
 Low level 7 (18) 0 (0) 143 (28)
 Medium level 15 (39) 12 (40) 246 (48)
 High level 17 (44) 18 (60) 97 (19)
 Missing 0 (0) 0 (0) 22 (4)
Marital status‖, n (%) 0.303§ n.a.
 Relationship 24 (62) 22 (73) –
 No relationship 15 (38) 8 (27) –
Marital status‖, n (%) n.a. n.a.
 Not married and not living together – – 299 (59)
 Married or living together – – 192 (38)
 Missing – – 17 (3)
†Mann–Whitney U test; ‡Fisher’s exact test; §Chi square test; ‖answer options regarding marital status of two different questionnaires were  
non-mergeable, therefore these are shown separately. Missing values were excluded for statistical testing (pairwise deletion). Continuous variables are 
presented as median (range). *Indicates a statistically significant difference (P < 0.01).
CCS, childhood cancer survivors; DTC, differentiated thyroid carcinoma; n.a., not applicable.
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Item scores: Item scores regarding social development, 
autonomy development and psychosexual development 
during or after secondary school did not differ between 
survivors of childhood DTC and the peer controls or the 
comparison group (Supplementary Table 1a, b and c).
II) Comparison to survivors of other types of 
childhood cancer
Sample characteristics
Age at diagnosis was significantly different between 
survivors of childhood DTC and other CCS 
(15.6  vs  6.3  years old, respectively, P < 0.001); the large 
majority (35 out of 39, 90%) of survivors of childhood 
DTC were diagnosed during secondary school. We 
therefore chose to focus primarily on survivors (DTC and 
other CCS) diagnosed at age ≥12 years (the age at which 
Dutch children generally start secondary school).
Thirty-five of the DTC survivors were diagnosed at age 
≥12 years (Supplementary Fig. 1). Of the 350 CCS non-
affected with thyroid cancer 76 were diagnosed at age 
≥12 years.
As shown in Table 3, the median age of these 35 DTC 
survivors at diagnosis was 15.8  years (range 12.0–18.7), 
Table 2 Scores on psychosocial developmental domains: comparison of survivors of childhood DTC with individuals non-affected 
with cancer.
DTC survivors Peer controls P value Comparison group P value
n 39 30 508
Social development† 22 (20.3, 23) 22 (18, 23) 0.592 21 (19, 23) 0.233
Autonomy development‡ 9 (8, 10) 10 (9, 11) 0.084 9 (8, 11) 0.241
Psychosexual development§ 8 (6.5, 8) 8 (6, 8) 0.841 8 (7, 8) 0.556
Scores are shown as median (p25, p27). Comparisons between DTC survivors and other groups were performed using Mann–Whitney U tests. Higher 
scores indicate earlier achievement or achievement of more psychosocial developmental milestones; †scale ranges 12–24; ‡scale ranges 6–12; §scale ranges 
4–8. Missing values were excluded from statistical testing (pairwise deletion). 
CCS, childhood cancer survivors; DTC, differentiated thyroid carcinoma.
Table 3 Characteristics of survivors of childhood DTC vs survivors of other childhood cancers (both diagnosed age ≥12 years old).
DTC survivors Other CCS P value
n 35 76
At diagnosis
 Age (years) 15.8 (12.0–18.7) 14.0 (12.0–17.0) <0.001*†
 Sex, n (%) <0.001*§
  Female 32 (91) 42 (55)
  Male 3 (9) 34 (45)
At follow-up
 Age at evaluation (years) 26.3 (18.8–35.7) 26.2 (18.9–31.1) 0.741†
 Follow-up period (years) 10.7 (5.0–23.3) 12.0 (6.2–18.1) 0.088†
 Employment, n (%) 1.000‡
  Employed and/or student 34 (97) 72 (95)
  Not employed and no student 1 (3) 3 (4)
  Missing 0 (0) 1 (1)
 Completed education, n (%) 0.237§
  Low level 6 (17) 15 (20)
  Medium level 13 (37) 36 (47)
  High level 16 (46) 21 (28)
  Missing 0 (0) 4 (5)
 Marital status‖, n (%) n.a.
  Relationship 23 (66) –
  No relationship 12 (34) –
  Not married and not living together – 31 (55)
  Married or living together – 31 (41)
  Missing – 3 (4)
†Mann–Whitney U test; ‡Fisher’s exact test; §Chi square test; ‖answer options regarding marital status of two different questionnaires were  
non-mergeable, therefore these are shown separately. Missing values were excluded for statistical testing (pairwise deletion). Continuous variables are 
presented as median (range). *Indicates a statistically significant difference (P < 0.01).
CCS, childhood cancer survivors; DTC, differentiated thyroid carcinoma; n.a., not applicable.
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and the median age at diagnosis of CCS was 14.0 years 
(range 12.0–17.0, P < 0.001). The group of DTC survivors 
included significantly more females than the CCS 
(91%  vs 55%, P < 0.001). Median follow-up period for 
DTC survivors was 10.7  years (range 5.0–23.3), and for 
the CCS, it was 12.0 years (range 6.2–18.1, P = 0.088). DTC 
survivors and CCS did not differ significantly on other 
characteristics. Ninety-seven percent of the CCS group 
were Dutch; this was not significantly different from the 
DTC survivors (P = 1.000).
Psychosocial development
Scale scores: DTC survivors scored higher on social 
development than did CCS (both diagnosed at ≥12 years, 
22 (21, 23) vs 21 (19, 22) out of 24, respectively, 
P = 0.005). DTC survivors also scored higher on social 
development compared to survivors of childhood 
leukemia diagnosed at age ≥12 years (22 (21, 23) vs 20 
(18, 22) respectively, P = 0.001), but their scores were 
not significantly different from those of survivors of 
solid tumors or brain tumors. Scale scores of CCS and 
subgroups of CCS, compared to DTC survivors, did not 
differ on autonomy development and psychosexual 
development ( Table 4).
Item scores: Given the age at diagnosis of DTC 
survivors, only items that apply to the period during 
or after secondary school are discussed. Item scores 
regarding social development, autonomy development, 
and psychosexual development during or after secondary 
school did not differ between survivors of DTC and CCS 
diagnosed at ≥12  years old (Fig.  1 and Supplementary 
Table 2a, b and c).
Characteristics and psychosocial development scale 
scores of DTC survivors and CCS diagnosed at all ages are 
shown in Supplementary Tables 3 and 4.
Possible determinants of psychosocial development
Disease- treatment and, follow-up characteristics were 
not significantly associated with scores on domains of 
psychosocial development (Supplementary Table 5).
Discussion
The current study shows similar achievement of 
psychosocial developmental milestones in long-term 
survivors of childhood DTC as compared to non-affected 
groups. A slightly better social development in DTC 
survivors was observed compared to other CCS; differences 
with leukemia survivors were the most pronounced. 
Medical characteristics were not associated with a better 
or worse psychosocial development. Altogether, this 
indicates that even though the diagnosis of DTC during 
childhood is a life-altering event, the disease does not 
seem to have consequences related to altered psychosocial 
development. Current results align with the overall 
normal QoL reported in a previous study describing the 
same cohort (19).
Current results imply that survivors of childhood DTC 
may be less restricted in their psychosocial development 
than other CCS; previous studies report hampered 
psychosocial development in other CCS compared to a 
non-affected comparison group of similar sex and age (7). 
This indicates that the degree to which a child is hindered 
in his or her development depends on the type of cancer 
(13). For instance, survivors of brain tumors and CCS 
treated with neurotoxic treatment (i.e. cranial irradiation, 
intrathecal chemotherapy and specific intravenous 
chemotherapies) were found to be most vulnerable to 
impairment of psychosexual and social development 
as compared to other CCS (10, 11, 13, 20). However, 
this finding was not confirmed in the current study. 
Table 4 Scores on psychosocial developmental domains: comparison of survivors of childhood DTC with survivors of other 
childhood cancers (both diagnosed age ≥12 years old).
 
 
 
DTC 
survivors
Childhood cancer survivors (CCS)
 
Total CCS
 
P value
Leukemia/
lymphoma
 
P value Solid tumors
 
P value Brain tumors
 
P value
n 35 76 45 23 8
Social development† 22 (21, 23) 21 (19, 22) 0.005 20 (18, 22) 0.001 22 (19, 23) 0.164 21.5 (20.3, 22.8) 0.391
Autonomy development‡ 9 (8, 10) 9 (8, 10) 0.688 10 (8, 10) 0.753 9 (8, 10.5) 0.677 9 (7.5, 11) 0.890
Psychosexual development§ 8 (7, 8) 7 (6, 8) 0.020 7 (6, 8) 0.040 7 (6, 8) 0.083 5.5 (4.3, 8) 0.097
Scores are shown as median (p25, p27). Comparisons between DTC survivors and other groups were performed using Mann–Whitney U tests.  
Higher scores indicate earlier achievement or achievement of more psychosocial developmental milestones; †scale ranges 12–24; ‡scale ranges 6–12; 
§scale ranges 4–8. Missing values were excluded from statistical testing (pairwise deletion). P values in bold indicate a significant value (P < 0.01).
CCS, childhood cancer survivors; DTC, differentiated thyroid carcinoma.
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This could be due to the fact that results in the current 
study were based on brain tumor survivors diagnosed 
during secondary school: brain tumor survivors diagnosed 
at younger ages were not represented while younger age 
at diagnosis of a brain tumor is associated with more 
developmental impairment (21).
Current results allow for conclusions regarding the 
majority of survivors of childhood DTC that was diagnosed 
during secondary school. Diagnosis of childhood DTC 
before secondary school occurs less frequently, therefore, 
concise conclusions cannot be made.
Factors that could interfere with psychosocial 
development (e.g. sex, age at diagnosis, age at follow-up, or 
follow-up duration Supplementary Table 5) were evaluated, 
but surprisingly showed no significant associations with 
psychosocial development. It may be that other, not 
investigated, factors may have played a role.
A first possible explanation for the normal psychosocial 
development of survivors of childhood DTC could lie in 
the excellent prognosis of the disease. In addition, the 
indolent course of DTC allows for flexibility in treatment, 
thus accommodating school schedules. In general, 
attending school benefits social development. The more 
favorable social development in DTC survivors compared 
to other CCS emphasizes this explanation. However, this 
statement remains speculative since we did not study 
school attendance. DTC treatment modalities differ from 
those of other types of cancer, using chemotherapeutics 
administered over longer periods of time. Another 
explanation could be the age upon diagnosis of most 
children with DTC. Relatively older upon diagnosis, these 
children as well as their parents have already experienced 
considerable developmental progression. For example, 
the foundations for social interactions (friendly as well as 
romantic) have already been formed. Lastly, fluctuations 
in thyroid hormone levels during periods of thyroid 
hormone withdrawal or long-term treatment effects of 
DTC, such as a weakened voice or the need for medication 
monitoring, may have less impact on psychosocial 
development than the aforementioned neurotoxicity 
and other physical or mental sequelae involved in other 
childhood cancer treatments (9, 10, 12, 22). It is common 
practice to substitute DTC survivors with levothyroxine 
after initial treatment and only use triiodothyronine in 
preparation for treatment with 131-I (23). As a result, 
current results suggest that neurological development of 
childhood DTC survivors is not affected by this approach 
to treatment.
Strengths and limitations
There is a great lack of knowledge regarding the long-
term impact of childhood thyroid cancer on psychosocial 
domains (23). A strength of the current study is that it 
is the first to evaluate psychosocial development in a, 
though relatively small, unique cohort of survivors of 
childhood DTC. Using various groups for comparison 
allowed psychosocial development in these survivors 
to be placed in different perspectives. However, when 
interpreting the results, one must keep in mind the 
limitations of the study. One cannot use the results 
of this cross-sectional design in long-term survivors 
to elaborate about psychosocial development in the 
first 5  years after diagnosis, but eventual long-term 
results are promising. Not all predictors of psychosocial 
development were evaluated; for instance, we did not 
include the dependency of autonomy development on 
Figure 1
Scores of survivors of childhood DTC (n = 35) and childhood 
cancer survivors (CCS, n = 76) of other types of cancer, both 
diagnosed at age ≥12 years old, on individual items of the 
CoLQ. Scores indicate the percentage of the group that has 
reached the developmental milestone. Dark bars: DTC 
survivors, light bars: other CCS. An asterisk (*) indicates a 
P value <0.01.
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parenting behavior. Moreover, since most DTC survivors 
were diagnosed during secondary school, the items 
regarding elementary school were less relevant for the 
current population. However, the CoLQ is only validated 
containing all items (7).
Clinical implications
Current results may be reassuring for children newly 
diagnosed with DTC, and for their families and 
caregivers, regarding the possible psychosocial impact 
of their disease. However, the results do not imply that 
physicians need not monitor problems with psychosocial 
development in these survivors. This study presents data 
of a group of survivors, but individual differences should 
not be overlooked. Presenting patients with thyroid 
cancer as a good cancer makes them feel that physicians 
are downplaying their cancer experiences (24).
In conclusion, the current study aimed to evaluate 
the achievement of psychosocial developmental 
milestones in survivors of childhood DTC and found no 
delay in autonomy, social, and psychosexual domains 
after diagnosis compared to individuals non-affected with 
cancer. It did find a slightly more favorable development 
in DTC survivors compared to other CCS. However, before 
drawing definite conclusions, current findings need to be 
confirmed in subsequent studies.
Supplementary data
This is linked to the online version of the paper at https://doi.org/10.1530/
EJE-17-0741.
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